Novartis’ Gilenya reduced the risk of MS disability progression, analysis shows April 11, 2011 CenterWatch Staff
Prolor Biotech reports positive results of its long-acting human growth hormone April 11, 2011 CenterWatch Staff
Vanda begins trial for long-acting injectable to treat schizophrenia April 11, 2011 CenterWatch Staff
Blueprint Medicines secures $40 Million in Series A for cancer treatment April 11, 2011 CenterWatch Staff